全文获取类型
收费全文 | 46719篇 |
免费 | 3931篇 |
国内免费 | 110篇 |
专业分类
耳鼻咽喉 | 375篇 |
儿科学 | 1898篇 |
妇产科学 | 1292篇 |
基础医学 | 6736篇 |
口腔科学 | 967篇 |
临床医学 | 6470篇 |
内科学 | 9075篇 |
皮肤病学 | 895篇 |
神经病学 | 4813篇 |
特种医学 | 1076篇 |
外科学 | 4100篇 |
综合类 | 404篇 |
一般理论 | 62篇 |
预防医学 | 5694篇 |
眼科学 | 669篇 |
药学 | 2631篇 |
2篇 | |
中国医学 | 54篇 |
肿瘤学 | 3547篇 |
出版年
2024年 | 41篇 |
2023年 | 396篇 |
2022年 | 396篇 |
2021年 | 1266篇 |
2020年 | 938篇 |
2019年 | 1396篇 |
2018年 | 1532篇 |
2017年 | 1204篇 |
2016年 | 1331篇 |
2015年 | 1400篇 |
2014年 | 1786篇 |
2013年 | 2622篇 |
2012年 | 3658篇 |
2011年 | 3771篇 |
2010年 | 2069篇 |
2009年 | 1837篇 |
2008年 | 3051篇 |
2007年 | 3139篇 |
2006年 | 3081篇 |
2005年 | 2901篇 |
2004年 | 2810篇 |
2003年 | 2575篇 |
2002年 | 2317篇 |
2001年 | 365篇 |
2000年 | 259篇 |
1999年 | 313篇 |
1998年 | 522篇 |
1997年 | 391篇 |
1996年 | 348篇 |
1995年 | 339篇 |
1994年 | 267篇 |
1993年 | 265篇 |
1992年 | 186篇 |
1991年 | 158篇 |
1990年 | 143篇 |
1989年 | 111篇 |
1988年 | 124篇 |
1987年 | 89篇 |
1986年 | 94篇 |
1985年 | 98篇 |
1984年 | 100篇 |
1983年 | 101篇 |
1982年 | 127篇 |
1981年 | 123篇 |
1980年 | 103篇 |
1979年 | 62篇 |
1978年 | 66篇 |
1977年 | 50篇 |
1976年 | 47篇 |
1972年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Hypertension and dementia 总被引:2,自引:0,他引:2
Hypertension is one of the principal risk factors for cerebrovascular diseases. Several epidemiologic studies have also indicated
a positive correlation between cognitive decline or dementia and blood pressure level. Indeed, the results of most longitudinal
studies show that cognitive functioning is often inversely proportional to blood pressure values measured 15 or 20 years previously.
Cerebral infarcts, lacunae, and white matter changes are implicated in the pathogenesis of vascular dementia, but may also
favor the development of Alzheimer’s disease. Microcirculation disorders and endothelial dysfunctions are also advanced to
explain the deterioration in cognitive functions in hypertensive subjects. Data from recent therapeutic trials open the way
to the prevention of dementia (vascular or Alzheimer’s type) by antihypertensive treatments and must be confirmed by other
studies. 相似文献
992.
Steiner AZ Chang L Ji Q Ookhtens M Stolz A Paulson RJ Stanczyk FZ 《The Journal of clinical endocrinology and metabolism》2008,93(4):1298-1303
CONTEXT: Dihydrotestosterone (DHT), the primary active androgen in peripheral target tissues, is metabolized by 3alpha-hydroxysteroid dehydrogenase type III (3alpha-HSD), encoded by the AKR1C2 gene, forming 5alpha-androstane-3alpha,17beta-diol (3alpha-diol). 3alpha-HSD may play a role in the pathogenesis of hirsutism. OBJECTIVES: Our objective was to evaluate the role of 3alpha-HSD in hirsutism by comparing 1) tissue levels of active androgens, 2) relative gene expression of AKR1C2, and 3) activity of 3alpha-HSD in genital skin from normal and hirsute women. DESIGN: Genital skin was obtained from normal and hirsute women. After homogenization, testosterone (T) and DHT levels were quantified by conventional RIA. From isolated RNA, relative expression of AKR1C2 was determined by real-time PCR. In addition, minced genital skin was incubated with [(3)H]DHT, and the product, [(3)H]3alpha-diol, was quantified by radio-HPLC. SETTING: The study took place at an inner-city hospital. Patients: Patients included women undergoing posterior colporrhaphy. MAIN OUTCOME MEASURES: We assessed 1) tissue levels of T, DHT, and 3alpha-diol; 2) relative expression of AKR1C2; and 3) conversion ratio of [(3)H]3alpha-diol to [(3)H]DHT. Results: In genital skin, tissue DHT and T concentrations in hirsute women were 1.90-fold and 1.84-fold higher than in normal women (P =0 .002 and 0.03), and relative expression of AKR1C2 mRNA was reduced approximately 7-fold (P = 0.04). Genital skin from hirsute women showed less metabolism of [(3)H]DHT to [(3)H]3alpha-diol (conversion ratio, 0.24 +/- 0.19 vs. 0.85 +/- 0.55, P = 0.01). CONCLUSIONS: In genital skin of hirsute women, reduced AKR1C2 gene expression and 3alpha-HSD activity results in decreased DHT metabolism and elevated tissue levels of DHT. Diminished DHT metabolism may play an important role in the pathogenesis of hirsutism. 相似文献
993.
Blomgren K Alho OP Ertama L Huovinen P Korppi M Mäkelä M Penttilä M Pitkäranta A Savolainen S Varonen H Suonpää J;Finnish Society of Otorhinolaryngology committee 《Scandinavian journal of infectious diseases》2005,37(4):245-250
These clinical practice guidelines aim at providing assistance mainly to primary health care physicians for the diagnosis and management of acute sinusitis. Despite the huge impact of upper respiratory infections, criteria for diagnoses are often vague, and physicians are often uncertain of their diagnoses. This is not surprising, as the sole definition of acute sinusitis is somewhat confusing, not to mention the existing discrepancies between treatments, even among specialists. The Finnish Society of Otorhinolaryngology has set up a committee to evaluate existing data on acute sinusitis and to formulate these guidelines. The committee comprised Finnish experts in adult and paediatric otorhinolaryngology, clinical microbiology, radiology, paediatrics, and epidemiology. Recommendations given are based on the principles of evidence-based medicine, with the level of evidence presented. 相似文献
994.
995.
Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions 总被引:7,自引:0,他引:7
O'Toole D Palazzo L Hammel P Ben Yaghlene L Couvelard A Felce-Dachez M Fabre M Dancour A Aubert A Sauvanet A Maire F Lévy P Ruszniewski P 《Gastrointestinal endoscopy》2004,59(7):823-829
BACKGROUND: Benign pancreatic serous cystadenoma usually is morphologically distinguishable from mucinous cystadenomas, which require resection because of their malignant potential. A macrocystic variant of serous cystadenoma recently has been described, rendering this important distinction more difficult. The aim of this study was to determine the EUS and tumor marker characteristics of mucinous cystadenoma compared with macrocystic serous cystadenomas. METHODS: Medical records for consecutive patients seen between 1995 and 2002, with a histopathologic diagnosis of mucinous cystadenoma or macrocystic serous cystadenoma after surgery, who had undergone a detailed EUS examination, including EUS-guided FNA, were retrospectively reviewed. RESULTS: A resection specimen was available for 32 mucinous cystadenomas and 9 macrocystic serous cystadenomas. No significant differences were observed with regard to clinical data (age, gender, presence of symptoms), lesion size, and location within the pancreas. All mucinous cystadenomas had a discernible cyst wall (thickened, 66%; focal parietal nodules, 25%) compared with 56% of macrocystic serous cystadenomas (p<0.0001). A thick echo content also was more frequent in mucinous cystadenoma (56% vs. 11%; p=0.04; statistical significance removed by the Bonferroni correction). Microcysts were only observed in macrocystic serous cystadenomas (44%; p=0.0008). The combination of a cyst wall that is thickened and the absence of microcysts had a sensitivity of 100% and specificity of 78% for the diagnosis of mucinous cystadenoma compared with macrocystic serous cystadenoma. Although intracystic carbohydrate-associated antigen 72-4 and mucins M1 were non-discriminatory, low carcinoembryonic antigen (<5 ng/mL) and carbohydrate-associated antigen 19-9 (<50,000 U/mL) values were found in macrocystic serous lesions (respectively, 100% and 100%; p=0.0002 and p=0.0002). CONCLUSIONS: Although there is considerable overlap, helpful EUS characteristics that differentiate mucinous cystadenoma from macrocystic serous cystadenoma include a thick cyst wall and microcysts. These features, coupled with analysis of aspirated fluid for tumor markers (especially carcinoembryonic antigen), should help to confirm the diagnosis. 相似文献
996.
Chen CC Zimmer A Sun WH Hall J Brownstein MJ Zimmer A 《Proceedings of the National Academy of Sciences of the United States of America》2002,99(13):8992-8997
Acid-sensing ion channel 3 (ASIC3), a proton-gated ion channel of the degenerins/epithelial sodium channel (DEG/ENaC) receptor family is expressed predominantly in sensory neurons including nociceptive neurons responding to protons. To study the role of ASIC3 in pain signaling, we generated ASIC3 knockout mice. Mutant animals were healthy and responded normally to most sensory stimuli. However, in behavioral assays for pain responses, ASIC3 null mutant mice displayed a reduced latency to the onset of pain responses, or more pain-related behaviors, when stimuli of moderate to high intensity were used. This unexpected effect seemed independent of the modality of the stimulus and was observed in the acetic acid-induced writhing test (0.6 vs. 0.1-0.5%), in the hot-plate test (52.5 and 55 vs. 50 degrees C), and in tests for mechanically induced pain (tail-pinch vs. von Frey filaments). We postulate that ASIC3 is involved in modulating moderate- to high-intensity pain sensation. 相似文献
997.
998.
OBJECTIVE: Oral but not transdermal oestrogen administration reduces IGF-I, and increases GH binding protein (GHBP) reflecting effects on hepatic endocrine function in postmenopausal women. As progestogens attenuate the effects of oestrogen on circulating lipid levels according to their androgenic properties, we have investigated the impact of progestogen types on the hepatic endocrine effects of oestrogen. DESIGN: Four progestogens differing in androgenicity were co-administered in a monthly cyclical regimen in random order to postmenopausal women receiving either oral (n = 9, premarin 1.25 mg) or transdermal (n = 10, Estraderm 100 microg patches twice weekly). The four progestogens were cyproterone acetate (CA 5 mg, antiandrogenic), dydrogesterone (20 mg, neutral), medroxyprogesterone acetate (MPA 10 mg, mildly androgenic), norethisterone (2.5 mg, androgenic). PATIENTS: Nineteen postmenopausal women (age 57 +/- 3 years, mean +/- SE) were studied. MEASUREMENTS: The effects of oestrogen alone and the combined effects with each progestogen type on IGF-I, GHBP, SHBG, cholesterol, triglycerides and lipoprotein(a) were investigated. RESULTS: Mean IGF-I fell while GHBP and SHBG levels increased with oral (P < 0.01) but not transdermal oestrogen administration. When the combined effects were examined, progestogens did not affect IGF-I, GHBP and SHBG during oral oestrogen treatment, while they significantly increased (P < 0.01) mean IGF-I levels during transdermal therapy. Among the progestogen types, only norethisterone prevented the fall in IGF-I induced by oral oestrogen. During transdermal therapy, MPA and norethisterone but not CA or dydrogesterone significantly increased (P < 0.005) IGF-I. The rise in GHBP induced by oral oestrogens tended to be lower during co-administration of MPA and norethisterone. The increase in SHBG induced by oral oestrogen was attenuated (P < 0.05) by norethisterone which was the only progestogen that lowered SHBG (P < 0.05) during transdermal oestrogen treatment. Mean IGF-I was higher (P < 0.001), GHBP and SHBG lower during co-administration of androgenic progestogens (MPA and norethisterone). CONCLUSIONS: Oestrogen effects on IGF-I, GHBP and SHBG are dependent on the route of administration with progestogens having variable effects. Among the progestogen types, norethisterone, the most androgenic, had the greatest effect, particularly on IGF-I. Progestogens modulate the effects of oestrogen on hepatic endocrine function in relation to their intrinsic androgenic properties. The modulatory effects of progestogens on IGF-I during oestrogen therapy may have long-term implications for lean body mass. 相似文献
999.
De Groot AS Moise L McMurry JA Wambre E Van Overtvelt L Moingeon P Scott DW Martin W 《Blood》2008,112(8):3303-3311
We have identified at least 2 highly promiscuous major histocompatibility complex class II T-cell epitopes in the Fc fragment of IgG that are capable of specifically activating CD4(+)CD25(Hi)FoxP3(+) natural regulatory T cells (nT(Regs)). Coincubation of these regulatory T-cell epitopes or "Tregitopes" and antigens with peripheral blood mononuclear cells led to a suppression of effector cytokine secretion, reduced proliferation of effector T cells, and caused an increase in cell surface markers associated with T(Regs) such as FoxP3. In vivo administration of the murine homologue of the Fc region Tregitope resulted in suppression of immune response to a known immunogen. These data suggest that one mechanism for the immunosuppressive activity of IgG, such as with IVIG, may be related to the activity of regulatory T cells. In this model, regulatory T-cell epitopes in IgG activate a subset of nT(Regs) that tips the resulting immune response toward tolerance rather than immunogenicity. 相似文献
1000.
Laumonier H Rullier A Saric J Balabaud C Bioulac-Sage P 《World journal of gastroenterology : WJG》2008,14(30):4830-4833
We present 2 cases of hepatocyte nuclear factor 1α (HNF1α)-mutated adenomatosis, discovered for reasons unrelated to this disease, and identified using immunohistochemical methods. These new tools may further our understanding of the link between adenomas/adenomatosis subtypes and their complications, and their association with other abnormalities. 相似文献